SSA
RXDX

Schonfeld Strategic Advisors’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Schonfeld Strategic Advisors’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-22,068
Closed -$2.37M – 2483
2023
Q1 		$2.37M Buy
22,068
+2,094
+10% +$225K 0.02% 645
2022
Q4 		$2.2M Sell
19,974
-46,676
-70% -$5.13M 0.02% 785
2022
Q3 		$3.93M Buy
+66,650
New +$3.93M 0.03% 608